Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Biogen Receives FDA Approval For Aduhelm

FDA
News

Biogen Receives FDA Approval For Aduhelm

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761178

byBenzinga Newsdesk

February 9, 2023

1 minute read

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761178

Tesla, Apple, Western Alliance, ImmunoGen, Qualcomm: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

May 3, 9:42 PM

U.S. markets ended in the red on Wednesday after recording initial gains following the Federal Reserve hiking the…

AAPL

Zoetis’ Osteoarthritis Med for Dogs Set to Deliver Significant Advantages In 2024, Analyst Says

By Vandana Singh

May 8, 2:47 PM

Friday, the FDA approved Zoetis Inc's (NYSE: ZTS) Librela (bedinvetmab) for the control of pain associated with

ZTS

Red White & Bloom FY22 Revenue Grows 161.6%, Here Is What You Need To Know

By Vuk Zdinjak

May 16, 8:12 AM

Red White & Bloom Brands Inc. (OTCEM:RWBYF) (CSE:RWB) filed its consolidated audited financial statements, revealing revenue of CA$97.5 million ($72.4 million) for fiscal year 2022, an increase of 161.6% compared to CA$37.3 million in fiscal year 2021.

CSE:RWB